KFDA to approve Green Cross A hepatitis vaccine.

Published: 2006-04-25 06:58:00

Updated: 2006-04-25 06:58:00

Green Cross Vaccine announced that as of April 17 the company took a KFDA approval of Epaxal Berna prefilled syringe injectable vaccine (an absorbed A viral hepatitis Virosome vaccine)

Epaxal Berna is a novel A hepatitis vaccine that was prepared with Virosome as an absorber to enhance its tol...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK